Clinical-epidemiological profile and prevalence of impaired Geriatric 8 score in elderly with cancer at systemic antineoplastic treatment
DOI:
https://doi.org/10.15448/2357-9641.2023.1.43997Keywords:
aged, neoplasms, frailty, medical oncology, geriatrics, antineoplastic agentsAbstract
Introduction: the elderly represent a population with heterogeneous characteristics active in the health-disease process. The Geriatric 8 scale represents a screening tool used in elderly people with cancer to identify frail individuals.
Aim: to describe the clinical-epidemiological profi le and the prevalence of the impaired Geriatric 8 score in elderly with cancer undergoing systemic antineoplastic treatment.
Method: observational, cross-sectional study in patients aged ≥60 years who did systemic antineoplastic treatment for solid tumors in two tertiary hospitals from May to September 2020.
Results: the study included 178 individuals with an average age of 70, 8 ± 7.6 years, 57.1% were female and 82.6% with some comorbidities. The main neoplasms identified were lung (21.9%), breast (15.7%) and colorectal (14.0%), diverse according to sex, and 72.5% had metastatic disease. The prevalence of score ≤ 14 by the Geriatric 8 scale was 66.9%.
Conclusion: the characterization of the clinical-epidemiological profile of elderly with cancer in a population allows the identification of variables that directly and indirectly affect the treatment and evolution of neoplastic diseases. The high prevalence of impaired Geriatric 8 score demonstrates the susceptibility of the population studied, suggesting the need to develop strategies to improve the prognosis and quality of life of these individuals.
Downloads
References
Sung, H. et al. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71:209-49. DOI: https://doi.org/10.3322/caac.21660
Mohile SG, Dale W, Somerfield MR, Schonberg MA, Boyd CM, Burhenn PS, et al. Practical Assessment and Management of Vulnerabilities in Older Patients Receiving Chemotherapy: ASCO Guideline for Geriatric Oncology. J Clin Oncol. 2018;36(22):2326-47. https://www.doi.org/10.1200/JCO.2018.78.8687. DOI: https://doi.org/10.1200/JCO.2018.78.8687
Zhang X, Meng X, Chen Y, Leng SX, ZhangH. The Biology of Aging and Cancer: Frailty, Inflammation, and Immunity. Cancer J. 2017;23(4):201-5. https://www.doi.org/10.1097/PPO.0000000000000270. DOI: https://doi.org/10.1097/00130404-201707000-00002
Kadambi S, Loh KP, Dunne R, Magnuson A, Maggiore R, ZittelJ, et al. Older adults with cancer and their caregivers - current landscape and future directions for clinical care. Nat Rev Clin Oncol. 2020;17(12):742-55. https://www.doi.org/10.1038/s41571-020-0421-z. DOI: https://doi.org/10.1038/s41571-020-0421-z
Miller KD, Nogueira L, Mariotto AB, Rowland JH, Yabroff KR, Alfano CM, Jemal A, et al. Cancer treatment and survivorship statistics, 2019. CA Cancer J Clin. 2019;69(5):363-85, 2019. https://www.doi.org/10.3322/caac.21565. DOI: https://doi.org/10.3322/caac.21565
Aaldriks AA, Maartense E, Nortier HJWR, van der Geest LGM, le Cessie S, Tanis BC, et al. Prognostic factors for the feasibility of chemotherapy and the Geriatric Prognostic Index (GPI) as risk profile for mortality before chemotherapy in the elderly. Acta Oncol. 2016;55(1):15-23, 2016. https://www.doi.org/10.3109/0284186X.2015.1068446. DOI: https://doi.org/10.3109/0284186X.2015.1068446
Boyle HJ et al. Updated recommendations of the International Society of Geriatric Oncology on prostate cancer management in older patients. Eur J Cancer. 2019 Jul;116:116-36. DOI: https://doi.org/10.1016/j.ejca.2019.04.031
van Walree IC et al. A systematic review on the association of the G8 with geriatric assessment, prognosis and course of treatment in older patients with cancer. J Geriatr Oncol. 2019 Nov;10(6):847-58. DOI: https://doi.org/10.1016/j.jgo.2019.04.016
Biganzoli L et al. Updated recommendations regarding the management of older patients with breast cancer: a joint paper from the European Society of Breast Cancer Specialists (EUSOMA) and the International Society of Geriatric Oncology (SIOG). Lancet Oncol. 2021 Jul;22(7):e327-40. DOI: https://doi.org/10.1016/S1470-2045(20)30741-5
Lenzi TCR, Reis CMS, Novaes MRCG. Epidemiological profile of elderly patients with non-melanoma skin cancer seen at the dermatology outpatient clinic of a public hospital. An. Bras. Dermatol. 2017;92(6):882-4. https://www.doi.org/10.1590/abd1806-4841.20175701. DOI: https://doi.org/10.1590/abd1806-4841.20175701
Shenvi CL, Platts-Mills TF. Managing the Elderly Emergency Department Patient. Ann EmergMed. 2019;73(3):302-7. https://www.doi.org/10.1016/j.annemergmed.2018.08.426. DOI: https://doi.org/10.1016/j.annemergmed.2018.08.426
IBGE. Instituto Brasileiro de Geografia e Estatística. Pesquisa Nacional de Saúde 2013: acesso e utilização dos serviços de saúde, acidentes e violência Brasil, grandes regiões e unidades da federação. Rio de Janeiro: IBGE; 2015.
Nunes BP, de Andrade FB, de Souza Jr PRB, Neri AL, Duarte YAO, Castro-Costa E, de Oliveira C. Multimorbidity: The Brazilian Longitudinal StudyofAging (ELSI-Brazil). Am J Epidemiol. 2018;187(7):1345-53. https://www.doi.org/10.1093/aje/kwx387. DOI: https://doi.org/10.1093/aje/kwx387
Santos EGA, de Souza JC, dos Santos ALS, Santos MIPO, Oliveira TNC. Perfil clínico-epidemiológico de idosos submetidos à quimioterapia antineoplásica atendidos em um hospital de referência oncológica do estado do Pará, Brasil. Rev Pan-AmazSaude. 2017;8(2):45-54. http://dx.doi.org/10.5123/s2176-62232017000200006. DOI: https://doi.org/10.5123/S2176-62232017000200006
ESMO. European Society of Medical Oncology. Handbook on Cancer in the Senior Patient [Internet]. 2015 [citado em 2 out. 2020]. Disponível em: https://oncologypro.esmo.org/education-library/esmo-handbooks/cancer-in-the-senior-patient.
Saracino RM, Rosenfeld B, Nelson CJ. Performance of four diagnostic approaches to depression in adults with cancer. Gen Hosp Psychiatry. 2018;51:90-5. https://www.doi.org/10.1016/j.genhosppsych.2018.01.006. DOI: https://doi.org/10.1016/j.genhosppsych.2018.01.006
Magnuson A, Sattar S, Nightingale G, Saracino R, Skonecki E, Trevino KM. A Practical Guide to Geriatric Syndromes in Older Adults With Cancer: A Focus on Falls, Cognition, Polypharmacy, and Depression. Am- SocClinOncolEduc Book. 2019;39:e96-e109. https://www.doi.org/10.1200/EDBK_237641. DOI: https://doi.org/10.1200/EDBK_237641
Soto-Perez-de-Celis E, Li D, Yuan Y, Lau YM, Hurria A. Functional versus chronological age: geriatric assessments to guide decision making in older patients with cancer. Lancet Oncol. 2018;19(6):e305-16. https://www.doi.org/10.1016/S1470-2045(18)30348-6. DOI: https://doi.org/10.1016/S1470-2045(18)30348-6
Horgan AM, Leighl NB, Coate L, Liu G, Palepu P, Knox JJ, et al. Impact and feasibility of a comprehensive geriatric assessment in the oncology setting: a pilot study. Am J Clin Oncol. 2012;35(4):322-8. https://www.doi.org/10.1097/COC.0b013e318210f9ce. DOI: https://doi.org/10.1097/COC.0b013e318210f9ce
Hamaker ME, Seynaeve C, Wymenga ANM, van Tinteren H, Nortier JWR, Maartense E, et al. Baseline comprehensive geriatric assessment is associated with toxicity and survival in elderly metastatic breast cancer patients receiving single-agent chemotherapy: results from the OMEGA study of the Dutch breast cancer trialists’ group. Breast. 2014;23(1):81-7. https://www.doi.org/10.1016/j.breast.2013.11.004. DOI: https://doi.org/10.1016/j.breast.2013.11.004
Extermann M, Reich RR, Sehovic M. Chemotoxicity recurrence in older patients: Risk factors and effectiveness of preventive strategies-a prospective study. Cancer. 2015;121(17):2984-92. https://www.doi.org/10.1002/cncr.29423. DOI: https://doi.org/10.1002/cncr.29423
Kirkhus L, Benth JS, Rostoft S, Grønberg BH, Hjermstad MJ, Selbæk G, et al. Geriatric assessment is superior to oncologists’ clinical judgement in identifying frailty. Br J Cancer 2017;117(4):470-7. https://www.doi.org/10.1038/bjc.2017.202. DOI: https://doi.org/10.1038/bjc.2017.202
Kotzerke D, Moritz F, Mantovani L, Hambsch P, Hering K, Kuhnt T, et al. The performance of three oncogeriatric screening tools - G8, optimized G8 and CARG - in predicting chemotherapy-related toxicity in older patients with cancer. A prospective clinical study. J GeriatrOncol. 2019;10(6):937-43. https://www.doi.org/10.1016/j.jgo.2019.04.004. DOI: https://doi.org/10.1016/j.jgo.2019.04.004
Takahashi M, Takahashi M, Komine K, Yamada H, Kasahara Y, Chikamatsu S, et al. The G8 screening tool enhances prognostic value to ECOG performance status in elderly cancer patients: A retrospective, single institutional study. PLoS One. 2017;12(6):e0179694, 2017. https://www.doi.org/10.1371/journal.pone.0179694. DOI: https://doi.org/10.1371/journal.pone.0179694
Wildes TM, Ruwe AP, Fournier C, Gao F, Carson KR, Piccirillo JF, et al. Geriatric assessment is associated with completion ofchemotherapy, toxicity and survival in older adults with cancer. J GeriatrOncol. 2013;4(3):227-34. https://www.doi.org/10.1016/j.jgo.2013.02.002. DOI: https://doi.org/10.1016/j.jgo.2013.02.002
Denewet N, Breucker S, Luce S, Kennes B, Higuet S, Pepersack T. Comprehensive geriatric assessment and comorbidities predict survival in geriatric oncology. ActaClinBelg. 2016;71(4):206-13. https://www.doi.org/10.1080/17843286.2016.1153816. DOI: https://doi.org/10.1080/17843286.2016.1153816
INCA. Instituto Nacional de Câncer. Estimativa 2020: incidência de câncer no Brasil. Rio de Janeiro: INCA; 2019.
American Cancer Society. Cancer Facts & Figures 2020 [Internet]. Atlanta: American Cancer Society; 2020 [citado em 6 jan. 2021]. Disponível em: https://www.cancer.org/research/cancer-facts-statistics/all-cancer-facts-figures/cancer-facts-figures-2020.html.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 PAJAR - Pan American Journal of Aging Research
This work is licensed under a Creative Commons Attribution 4.0 International License.
Copyright
The submission of originals to PAJAR implies the transfer by the authors of the right for publication. Authors retain copyright and grant the journal right of first publication. If the authors wish to include the same data into another publication, they must cite PAJAR as the site of original publication.
Creative Commons License
Except where otherwise specified, material published in this journal is licensed under a Creative Commons Attribution 4.0 International license, which allows unrestricted use, distribution and reproduction in any medium, provided the original publication is correctly cited.
